Lotvin Alan 4

Accession 0001127602-22-020596

CIK 0000064803other

Filed

Aug 4, 8:00 PM ET

Accepted

Aug 5, 4:50 PM ET

Size

27.6 KB

Accession

0001127602-22-020596

Form 4

Period: 2022-08-03

EVP, Transformation

Transactions

Exercise/Conversion
Common Stock
2022-08-04$62.21/sh+22,541$1,402,276→ 131,724.369 total
Exercise/Conversion
Common Stock
2022-08-03$54.19/sh+50,501$2,736,649→ 159,684.369 total
Exercise/Conversion
Stock Option
2022-08-03−50,501→ 20,201 total
Exercise: $54.19From: 2020-04-01Exp: 2029-04-01→ Common Stock (50,501 underlying)
Exercise/Conversion
Common Stock
2022-08-03$58.34/sh+70,398$4,107,019→ 179,581.369 total
Sale
Common Stock
2022-08-03$98.00/sh−70,398$6,899,004→ 109,183.369 total
Sale
Common Stock
2022-08-04$104.00/sh−22,541$2,344,264→ 109,183.369 total
Exercise/Conversion
Stock Option
2022-08-03−70,398→ 70,399 total
Exercise: $58.34From: 2021-04-01Exp: 2030-04-01→ Common Stock (70,398 underlying)
Exercise/Conversion
Stock Option
2022-08-04−22,541→ 0 total
Exercise: $62.21From: 2019-04-01Exp: 2025-04-01→ Common Stock (22,541 underlying)
Sale
Common Stock
2022-08-03$98.00/sh−50,501$4,949,098→ 109,183.369 total

Holdings

Common Stock (restricted)
5,827
Stock Option
Exercise: $104.82From: 2017-04-01Exp: 2023-04-01→ Common Stock (27,395 underlying)
27,395
Stock Option
Exercise: $78.05From: 2018-04-03Exp: 2024-04-03→ Common Stock (32,911 underlying)
32,911
Stock Option
Exercise: $74.30From: 2022-04-01Exp: 2031-04-01→ Common Stock (120,940 underlying)
120,940
Common Stock
(indirect: By Trust)
492
Stock Unit
30,176.673
Phantom Stock Credits
Exercise: $1.00→ Common Stock (554.276 underlying)
554.276
Stock Option
Exercise: $101.09From: 2023-04-01Exp: 2032-04-01→ Common Stock (77,962 underlying)
77,962

Footnotes (11)

[F1]All sales were effected pursuant to a Rule 10b5-1 plan.
[F10]Option became exercisable in four equal annual installments, commencing 4/1/2022.
[F11]Option becomes exercisable in four equal annual installments, commencing 4/1/2023.
[F2]The number of shares subject to the option were calculated using a 30-day average price.
[F3]Option became exercisable in four equal annual installments, commencing 4/1/2021.
[F4]Option became exercisable in four equal annual installments, commencing 4/1/2020.
[F5]Option became exercisable in four equal annual installments, commencing 4/1/2019.
[F6]Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
[F7]Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
[F8]Option became exercisable in four equal annual installments, commencing 4/1/2017.
[F9]Option became exercisable in four equal annual installments, commencing 4/3/2018.

Documents

1 file

CVS HEALTH Corp

CIK 0000064803

Entity typeother